| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 10/17/2006 | US7122193 Comprising peptide analogues which have a half-life which is clearly superior to that of natural proteins or that of synthetic peptides which are or are not derived from these natural proteins |
| 10/17/2006 | US7122190 Peptide containing amino acids 638 to 673 of the HIV-1LAI gp41 protein, and fragments, analogs and homologs of DP178, inhibitory of human and nonhuman retroviral, especially HIV, transmission to uninfected cells |
| 10/17/2006 | CA2177179C Antagonists to chaperonin 10 |
| 10/12/2006 | WO2006107183A1 Mussel bioadhesive |
| 10/12/2006 | WO2006106164A1 Dermopharmaceutical or cosmetic composition comprising enkephalin-derived peptides for reducing and/or eliminating facial wrinkles |
| 10/12/2006 | US20060229433 Modified antiviral peptides with increased activity and cell membrane affinity |
| 10/12/2006 | US20060229432 synthetic vaccine; HIV; multi-antigenic construct comprising carbohydrate antigens linked with polypeptides |
| 10/12/2006 | US20060229253 Pentapeptide compounds and uses related thereto |
| 10/12/2006 | US20060229252 Antimicrobial hexapeptides |
| 10/12/2006 | US20060229250 Ghrelin associated peptide and its uses |
| 10/12/2006 | US20060229249 Peptide substrates of a proteolytic ADAM33 polypeptide and assays using the same |
| 10/12/2006 | US20060229246 Peptide-enhanced transfections |
| 10/12/2006 | US20060229240 Point mutations; solid phase synthesis; for treating conditions characterized by decreases in bone mass such as osteoporosis |
| 10/12/2006 | US20060228752 Genetic polymorphisms in the preprotachykinin gene |
| 10/12/2006 | US20060228398 Purified, heat stable, amino terminus-methylated, carboxy-terminus reduced peptide isolated from Brevibacillus comprising {4-methyl-4-[-2-butenyl]-4,N-methyl-Threonine}-leucine-ornithine-isoleucine-valine-valine-lysine-valine-lysine-tyrosine-leucine-valine alcohol; immunomodulators; infections |
| 10/12/2006 | DE4237113B4 Peptide und deren Fusionsproteine, Expressionsvektor und Verfahren zur Herstellung eines Fusionsproteins Peptides and fusion proteins, expression vector and methods for producing a fusion protein |
| 10/12/2006 | CA2608165A1 Dermopharmaceutical or cosmetic composition comprising enkephalin-derived peptides for reducing and/or eliminating facial wrinkles |
| 10/11/2006 | EP1710251A1 Novel peptide, process for producing the same and pharmaceutical composition containing the peptide |
| 10/11/2006 | EP1709971A1 Peptide antigens useful for the prophylaxis, treatment and diagnosis of poxvirus infections |
| 10/11/2006 | EP1709084A1 Polypeptides for modulating binding of trp channel proteins and trp-associated proteins |
| 10/11/2006 | EP1709083A1 Adenocarcinoma specific antibody sam-6, and uses thereof |
| 10/11/2006 | EP1709075A2 Treatment of viral infections |
| 10/11/2006 | EP1709065A2 A counterion exchange process for peptides |
| 10/11/2006 | EP1708732A2 Synthetic hla binding peptide analogues and uses thereof |
| 10/11/2006 | EP1622929B1 Apo2l (trail) receptor binding peptides and uses thereof |
| 10/11/2006 | EP1504022B1 Process for the synthesis of peptide amides by side-chain attachment to a solid phase |
| 10/11/2006 | EP1348024B1 Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases |
| 10/11/2006 | EP1250600B1 Diagnosis of tauopathies determining tau/phospho-tau ratio |
| 10/11/2006 | EP0968230B1 Oxidized fragments of apolipoprotein b and their use |
| 10/11/2006 | EP0751782B1 Use of a non-neutralizing antibody specific for the beta-subunit of luteinizing hormone for enhancing fertility |
| 10/11/2006 | EP0668777B1 Prostate-specific membrane antigen |
| 10/11/2006 | CN1845920A 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 10/11/2006 | CN1845751A Stationary phases and a purification process using the stationary phases |
| 10/11/2006 | CN1844142A Process for synthesis of thymopentin |
| 10/11/2006 | CN1279053C Modulators for beta-amyloid peptide aggregation comprising D-amino acids |
| 10/10/2006 | US7119182 Recombinant thrombin receptor and related pharmaceuticals |
| 10/10/2006 | US7119171 A fibronectin type III (Fn3) monobody polypeptide consisting of two to six beta -strand domains with a loop region linked between each beta-strand domain, and such polypeptide is capable of binding to a target molecule |
| 10/10/2006 | US7119085 Inhibit amyloid protein deposits |
| 10/10/2006 | US7119073 Peptides and their use as inhibitors of hepatitis C virus ns3 protease |
| 10/10/2006 | US7119063 Alzheimer's disease therapy; polypeptides |
| 10/10/2006 | US7118872 Used in detection, isolation, and/or purification |
| 10/10/2006 | US7118748 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 10/10/2006 | CA2262778C Conformationally constrained backbone cyclized somatostatin analogs |
| 10/10/2006 | CA2212887C Monoclonal antibody specific for .beta.a4 peptide |
| 10/05/2006 | WO2006105392A2 Neuron targeting peptides |
| 10/05/2006 | WO2006103352A1 Use of compounds inducing synthesis of sirt proteins in or for preparing a cosmetic or pharmaceutical compositions |
| 10/05/2006 | WO2006103015A1 Antibacterial amide-macrocycles v |
| 10/05/2006 | WO2006054262A3 Use of phage display technique for identifying peptides capable of binding progenitor/stem cells, peptides thereby obtained and uses thereof |
| 10/05/2006 | WO2006020748A3 Gfp-snap25 fluorescence release assay for botulinum toxin protease activity |
| 10/05/2006 | WO2006014292A3 Oral vaccine for borrelia |
| 10/05/2006 | WO2003106643A8 Novel polynucleotides encoding lamprey gnrh-iii |
| 10/05/2006 | US20060223984 Gamma-conopeptides |
| 10/05/2006 | US20060223983 Lipopeptide stereoisomers, methods for preparing same and useful intermediates |
| 10/05/2006 | US20060223758 Treating treating angiogenic disease by administering therapeutically effective amount of compounds of the invention, for example, {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester; stability |
| 10/05/2006 | US20060223757 Applications in gene therapy, transgenic organisms, functional genomics, and other areas of cell and molecular biology. |
| 10/05/2006 | US20060223756 Endothelial cell specifically binding peptides |
| 10/05/2006 | US20060223752 Of pestviruses as drug delivery devices for type-specific diagnosis of infection, for eliciting antibiotic activity, and for transport of substances into a cell |
| 10/05/2006 | US20060223747 Therapeutic agent for soft tissue sarcoma |
| 10/05/2006 | US20060223743 Metabolites of cyclosporin analogs |
| 10/05/2006 | US20060222666 Clostridial toxin derivatives and methods for treating pain |
| 10/05/2006 | US20060222650 Broad spectrum pyrogenic antagonists and vaccines directed against pyrogenic exotoxins |
| 10/05/2006 | US20060222616 Cosmetic composition comprising a and a lipopeptide |
| 10/05/2006 | US20060222593 Peptide-chelate conjugates |
| 10/05/2006 | CA2602763A1 Means for the inhibition of anti-.beta.1-adrenergic receptor antibodies |
| 10/05/2006 | CA2602755A1 Antibacterial amide-macrocycles v |
| 10/04/2006 | EP1706131A2 Helical synthetic peptides that stimulate cellular cholesterol efflux |
| 10/04/2006 | EP1207167B1 Process for the preparation of lh-rh derivatives |
| 10/04/2006 | CN1842537A Peptides, fragments and derivatives thereof promoting cell adhesion and spreading |
| 10/04/2006 | CN1277840C Growth hormone releasing compound for treating tumor and inhibitor thereof |
| 10/03/2006 | US7115729 Isolated nucleic acid molecules which encode peptides which bind to MHC class II molecules, such as HLA-DR53 |
| 10/03/2006 | US7115715 Oncogenic protein for use in the diagnosis and treatment of tumors |
| 10/03/2006 | US7115707 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 10/03/2006 | US7115572 Indolicidin analogs with anti-microbial activity |
| 10/03/2006 | US7115571 of given amino acid sequence; D-amino acid linkage makes peptides resistant to proteolytic degradation in vivo; same activity as native IL-3 and also have neurotrophic activity |
| 10/03/2006 | US7115562 Peptides and their use to ameliorate cell death |
| 10/03/2006 | US7115378 Peptide biomarker and method of identification |
| 10/03/2006 | US7115363 Retrovirus capable of causing AIDS, means and methods for detecting it in vitro |
| 10/03/2006 | US7115272 Polypeptide comprising the immunogenic portion of wilms' tumor suppressor gene(wt1); tumor-associated antigen for use in cancer immunotherapy |
| 10/03/2006 | US7115267 polypeptide comprising hemoglobin alpha chain wherein the C-terminal hydrophobic domain has been substituted or deleted; regulating stem cell cycle and accelerating the post-chemotherapy peripheral blood cell recovery; inhibitors and stimulators of stem cell proliferation. |
| 10/03/2006 | US7115266 Angiotensin peptide-carrier conjugates and uses thereof |
| 10/03/2006 | US7115261 Combination of an alpha v beta 3 angiogenisis antagonist and an anti-tumor immunotherapeutic agent, which is a fusion protein of a cytokine IL-2 and an Ig heavy chain that immunoreacts with a tumor associated antigen target. |
| 10/03/2006 | US7115248 Conjugates of an annexin, a NxSy or a N4 chelating compound, and a hexose moiety recognized by a mammalian liver receptor that is conjugated to the annexin directly or via the chelating compound; useful for imaging vascular thrombi |
| 09/28/2006 | WO2006101782A2 A cysteine-containing peptide tag for site-specific conjugation of proteins |
| 09/28/2006 | WO2006100449A1 Improvements in or relating to treatment and prevention of viral infections |
| 09/28/2006 | WO2006100430A2 Polypeptides |
| 09/28/2006 | WO2006099779A1 A rgd-containing cyclic peptid and the active-targeting liposome thereof |
| 09/28/2006 | WO2003103572A3 Modified glucagon-like peptide-1 analogs |
| 09/28/2006 | US20060217530 Active against C5a receptors on polymorphonuclear leukocytes and macrophages; peptidomimetics; for treatment of inflammation |
| 09/28/2006 | US20060217320 Soft gel formulations for saquinavir |
| 09/28/2006 | US20060217317 Proteases of human kallikrein 2 (hK2); tissue imaging |
| 09/28/2006 | US20060217297 Dimerized peptide |
| 09/28/2006 | US20060217294 Compounds binding to p-selectin |
| 09/28/2006 | US20060216789 Method for the production of bacterial toxins |
| 09/28/2006 | US20060216778 Peptides and methods for deactivation of organophosphorus-based nerve agents and insecticides |
| 09/28/2006 | US20060216772 Interfacial biomaterials for binding metal substrates |
| 09/28/2006 | US20060216691 contacting MHC/HLA molecule with a pool of HCV-peptides whereby a HCV-peptide which has a binding capacity to MHC/HLA molecule binds to such MHC/HLA molecule and form a complex, detecting the complexe, assaying the complex in a T cell assay for T cell activation capacity, assaying T cell epitopes |
| 09/28/2006 | US20060216304 Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same |
| 09/28/2006 | US20060216301 Kdr peptides and vaccines containing the same |
| 09/28/2006 | US20060216299 Cell cycle targets and peptides |
| 09/28/2006 | DE19917195B4 Peptid zur Auslösung einer Immunreaktion gegen Tumorzellen, diese enthaltende pharmzeutische Zusammensetzungen, dessen Verwendungen, dafür codierende Nukleinsäure und diese Nukleinsäure enthaltender Expressionsvektor Peptide to induce an immune response against tumor cells containing this pharmzeutische compositions, uses thereof, nucleic acid coding therefor and these nucleic acid expression vector containing |